Key Highlights
- FDA refused to review Moderna's flu vaccine application due to insufficient study data.
- The vaccine utilizes mRNA technology, similar to that used in COVID vaccines.
- Moderna plans to request a meeting with the FDA to discuss the refusal.
- The decision could impact the approval process for other new and updated vaccines.
- Health Secretary Robert F. Kennedy Jr. has rejected mRNA vaccine technology.
